LAPTM5 and metabolic dysfunction-associated steatohepatitis: Further validation by mouse NASH model, the expression of CD53, LCP1, LAPTM5, NCKAP1L, C3AR1, FGL2, PLEK and SRGN were significantly upregulated (Figure 7D).